Clinical Advisor13h
GAD-7 Screening Increases Psychology Referrals at Syncope Clinic
Researchers compare GAD-7 with clinical identification as a means of anxiety screening among adolescent syncope patients.
The Manila Times3d
U.S. FDA approves Celltrion's OMLYCLO® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR®
OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for ...
MedPage Today3d
First Omalizumab Biosimilar Approved
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA ...
Medscape5d
Cases in Emergency Medicine
Clinical Case, July 24, 2012 Syncope and Fever in the ED: What's the Cause? This case illustrates 3 novel presentations of fever and syncope in adolescent patients. Learn the diagnosis.
WebMD1d
CANNABIS - Uses, Side Effects, and More
Cannabis (Cannabis sativa) is an herbal drug. It contains chemicals called cannabinoids, including delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). The cannabinoids in cannabis work by ...
Medscape1d
Nonunion of the Fractured Clavicle: Evaluation, Etiology, and Treatment
Although often viewed as benign injuries, clavicular fractures can lead to complications, particularly nonunions. The nonunion rate has been reported to be between 0.1% and 15%. Contributing ...